Fri, June 16, 2023
Thu, June 15, 2023
Wed, June 14, 2023
Tue, June 13, 2023
Mon, June 12, 2023

Tiago Fauth Initiated (ASND) at Hold and Held Target at $89 on, Jun 14th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. hold-and-held-target-at-89-on-jun-14th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Tiago Fauth of Credit Suisse, Initiated "Ascendis Pharma A/S" (ASND) at Hold and Held Target at $89 on, Jun 14th, 2023.

Tiago has made no other calls on ASND in the last 4 months.



There are 6 other peers that have a rating on ASND. Out of the 6 peers that are also analyzing ASND, 2 agree with Tiago's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Vikram Purohit of "Morgan Stanley" Reiterated at Hold and Held Target at $109 on, Monday, June 12th, 2023
  • Leland Gershell of "Oppenheimer" Downgraded from Buy to Hold on, Wednesday, April 5th, 2023


These are the ratings of the 4 analyists that currently disagree with Tiago


  • Andreas Argyrides of "Wedbush" Reiterated at Buy and Held Target at $187 on, Wednesday, June 7th, 2023
  • Li Watsek of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $152 on, Thursday, June 1st, 2023
  • David Lebowitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $146 on, Wednesday, April 5th, 2023
  • Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Decreased Target to $92 on, Tuesday, April 4th, 2023

Publication Contributing Sources